447 filings
Page 5 of 23
6-K
mi3a09
20 Jul 22
Current report (foreign)
4:42pm
6-K
qqsrez59w04un9t
7 Jul 22
Current report (foreign)
7:21pm
6-K
uz3xr eayy
5 Jul 22
Current report (foreign)
5:21pm
6-K
7a827 5d3qhvv9nq7fsd
15 Jun 22
Current report (foreign)
7:40pm
6-K
gvemmiida
6 Jun 22
This Document Is Important and Requires Your Immediate Attention
6:41pm
6-K
4yno2w87j0 ov77ty
20 May 22
Akari Therapeutics Presents Results from the CASCADE and CORONET Studies in COVID-19 at the American Thoracic Society (ATS) 2022 Annual Meeting
4:30pm
6-K
3tc7a
17 May 22
Akari Therapeutics Reports Full Year 2021 Financial Results and Highlights Clinical Progress
4:30pm
6-K
drgipv711u8
11 May 22
Current report (foreign)
8:52am
6-K
7576r6n7 3grhbor
9 May 22
Current report (foreign)
4:52pm
NT 20-F
hhhwr scecmej3pnj1w8
29 Apr 22
Notice of late annual filing (foreign)
12:00am
424B5
rr947 ul8r
9 Mar 22
Prospectus supplement for primary offering
9:39pm
6-K
xd6a2qgq lbonenklfbw
9 Mar 22
Akari Therapeutics, Plc Announces $9.0 Million Registered Direct Offering
9:35pm
6-K
kdmj7c38aiqdrz7e
4 Mar 22
Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
4:58pm
6-K
53wz 5ujs
28 Feb 22
Current report (foreign)
5:15pm
6-K
sw4jzpr
26 Jan 22
Current report (foreign)
4:30pm
6-K
abfu vyfogcs
19 Jan 22
FDA Agrees to Use of New Higher-Yielding Manufacturing Process for Nomacopan in Pivotal Clinical Studies
4:30pm
F-6EF
tpff2ajl10ax xkrek
7 Jan 22
Automatic registration for ADRs (foreign)
4:08pm
424B5
xfi62o5b0vmqh
3 Jan 22
Prospectus supplement for primary offering
9:41pm
6-K
n30g1 m89l
3 Jan 22
Akari Therapeutics, Plc Announces $6.0 Million Registered Direct Offering
9:40pm